tradingkey.logo
tradingkey.logo
Search

Allarity Therapeutics Inc

ALLR
Add to Watchlist
1.210USD
-0.020-1.63%
Close 07-31 16:00ETQuotes delayed by 15 min
19.25MMarket Cap
LossP/E TTM

ALLR Financials

See Allarity Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Allarity Therapeutics Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.17/-0.22
Revenue / Forecast
25.00K/0.00
Period
FY2025 Earnings
Revenue(YoY)
320.00K
--
EPS(YoY)
-0.78
95.01%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2020Q4
Financial Indicators
EPS
29.74%-0.17
87.72%-0.21
97.53%-0.19
95.53%-0.15
99.96%-0.25
99.16%-1.72
99.43%-7.71
99.98%-3.34
99.65%-664.13
99.91%-203.79
---1.35K
---15.77K
---190.68K
---238.74K
---1.66M
----
----
----
----
----
Revenue
--25.00K
--320.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
-0.66%-2.75M
54.74%-3.37M
76.91%-2.81M
-39.01%-2.32M
29.59%-2.73M
-332.81%-7.45M
-118.88%-12.15M
82.95%-1.67M
-15.61%-3.88M
44.49%-1.72M
16.92%-5.55M
-51.02%-9.79M
27.86%-3.36M
81.55%-3.10M
-394.67%-6.68M
---6.48M
---4.65M
-911.24%-16.82M
9.81%-1.35M
---1.66M
Net Margin
---11000.00%
---1054.06%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
1242.60%61.55%
28.65%7.67%
1.87%6.68%
51.14%6.48%
-79.60%4.58%
-45.61%5.96%
-21.99%6.56%
-61.29%4.29%
-24.82%22.47%
-57.23%10.96%
--8.41%
--11.08%
--29.89%
--25.63%
--5.83%
----
----
----
----
----
Revenue
--25.00K
--320.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
11.46%-2.69M
60.12%-2.92M
3.52%-2.52M
-22.60%-4.13M
28.40%-3.04M
-49.97%-7.32M
41.03%-2.61M
18.89%-3.37M
-15.59%-4.24M
-53.14%-4.88M
2.98%-4.43M
14.17%-4.16M
14.74%-3.67M
79.76%-3.19M
-14.80%-4.56M
---4.84M
---4.30M
-524.19%-15.74M
-128.65%-3.97M
---2.52M
Net Profit
-0.66%-2.75M
54.74%-3.37M
76.91%-2.81M
-39.01%-2.32M
29.59%-2.73M
-332.81%-7.45M
-118.88%-12.15M
82.95%-1.67M
-15.61%-3.88M
44.49%-1.72M
16.92%-5.55M
-51.02%-9.79M
27.86%-3.36M
81.55%-3.10M
-394.67%-6.68M
---6.48M
---4.65M
-911.24%-16.82M
9.81%-1.35M
---1.66M
Current assets
17.27%34.50M
-19.75%17.93M
0.49%20.47M
-2.00%20.88M
1182.00%29.42M
1033.49%22.34M
364.24%20.37M
478.11%21.31M
-22.62%2.29M
-60.33%1.97M
-27.62%4.39M
-63.57%3.69M
-82.77%2.97M
-76.40%4.97M
-20.62%6.06M
--10.12M
--17.21M
--21.05M
--7.63M
----
Total current liabilities
153.17%28.00M
-22.23%8.43M
18.49%8.79M
-14.86%9.04M
-38.58%11.06M
-23.49%10.84M
-52.91%7.41M
-16.20%10.62M
55.40%18.01M
26.24%14.17M
21.53%15.74M
10.52%12.67M
-8.83%11.59M
-45.84%11.22M
237.55%12.96M
--11.46M
--12.71M
--20.72M
--3.84M
----
Total assets
17.47%34.92M
-19.39%18.26M
2.05%20.80M
-31.34%21.20M
148.39%29.73M
90.95%22.65M
46.87%20.38M
130.02%30.88M
-5.77%11.97M
-18.44%11.86M
-23.49%13.88M
-42.21%13.43M
-59.41%12.70M
-70.70%14.54M
-50.97%18.13M
--23.23M
--31.29M
--49.63M
--36.99M
----
Total liabilities
153.17%28.00M
-22.23%8.43M
18.49%8.79M
-18.19%9.04M
-40.02%11.06M
-25.83%10.84M
-57.03%7.41M
-21.92%11.05M
41.40%18.44M
15.48%14.61M
17.92%17.25M
7.60%14.15M
-9.54%13.04M
-58.98%12.65M
99.71%14.63M
--13.15M
--14.42M
--30.85M
--7.33M
----
Total equity
-62.93%6.92M
-16.79%9.83M
-7.35%12.01M
-38.66%12.17M
388.50%18.67M
529.33%11.81M
483.71%12.96M
2843.62%19.84M
-1809.51%-6.47M
-245.56%-2.75M
-196.45%-3.38M
-107.17%-722.95K
-102.01%-338.88K
-89.94%1.89M
-88.19%3.50M
--10.08M
--16.87M
--18.78M
--29.66M
----
Net operating income
-67.27%-4.49M
-1.15%-3.24M
37.35%-3.41M
24.04%-5.48M
-91.99%-2.69M
-91.75%-3.21M
8.78%-5.44M
-189.10%-7.22M
56.29%-1.40M
31.64%-1.67M
-35.37%-5.97M
40.68%-2.50M
44.38%-3.20M
43.37%-2.45M
---4.41M
---4.21M
---5.75M
---4.32M
----
----
Net investment
---64.00K
97.32%-8.00K
----
----
----
---298.00K
----
----
----
100.00%0.00
--591.00K
--0.00
-100.00%0.00
-460.00%-18.00K
--0.00
--0.00
--809.00K
--5.00K
----
----
Net financing
77.15%19.74M
-105.67%-240.00K
-52.55%2.31M
-109.75%-2.56M
707.46%11.14M
711.30%4.24M
-24.53%4.87M
818.29%26.31M
19.17%1.38M
-47.80%522.00K
--6.45M
223.97%2.87M
--1.16M
-94.58%1.00M
--0.00
---2.31M
--0.00
--18.44M
----
----

FAQs

What is the total revenue of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its total revenue reached 320.00K, with a year-on-year change of 320.00K.

What are the current assets of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its current assets were 17.93M, with a year-on-year change of -19.75.

What are the total assets of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its total assets of Allarity Therapeutics Inc were 18.26M, with a year-on-year change of -19.39.

What are the total liabilities of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its total liabilities of Allarity Therapeutics Inc were 8.43M, with a year-on-year change of -22.23.

What is the total equity of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its total equity of Allarity Therapeutics Inc was 9.83M, with a year-on-year change of -16.79.

What is the net operating income of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its net operating income of Allarity Therapeutics Inc was -12.61M, with a year-on-year change of 28.13.

What is the net investment of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its net investment of Allarity Therapeutics Inc was -8.00K, with a year-on-year change of 97.32.

What is the net financing of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its net financing of Allarity Therapeutics Inc was 10.65M, with a year-on-year change of -71.06.

What is the Earnings Per Share (EPS) of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.78, with a year-on-year change of 95.01.

What is the net income of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its net income was -11.23M, with a year-on-year change of 55.35.

What is the debt-to-asset ratio of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 7.67, with a year-on-year change of 28.65.

What is the Return on Equity (ROE) of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -103.80, with a year-on-year change of 84.90.

What is the Return on Assets (ROA) of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -54.91, with a year-on-year change of 61.35.

What is the operating profit of Allarity Therapeutics Inc?

According to Allarity Therapeutics Inc's FY2025 earnings report, its operating profit was -12.61M, with a year-on-year change of 28.13.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.